You can buy or sell Check-Cap and other stocks, options, ETFs, and crypto commission-free!
Check-Cap Ltd. Ordinary Share, also called Check-Cap, is a clinical stage medical diagnostics company, which engages in developing gastrointestinal imaging devices. Read More It develops capsule-based system that utilizes low-dose X-rays to detect polyps, masses and colorectal cancer screening. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.
Mount Carmel, Haifa
52 Week High
52 Week Low
Yahoo FinanceMay 13
Check-Cap Announces Second Trial Site Joins Ongoing U.S. Pilot Study of C-Scan®
Mayo Clinic joins New York University in pilot study of C-Scan® in the U.S. ISFIYA, Israel, May 13, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (CHEK) (NASDAQ:CHEKW), (NASDAQ:CHEKZ), a clinical-stage medical diagnostics company advancing the development of C-Scan®, the first and only preparation-free ingestible capsule for the prevention of colorectal cancer through the detection of precancerous polyps, today announced that Mayo Clinic is the second trial site participating in the Co...
-$0.46 per share
-$0.44 per share